Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Probes for Oncology: Monitoring Therapy

  • You have access
    Monitoring chemotherapy-induced bone marrow toxicity and the potential protective effect of anti-CSF-1 using microPET/CT with 64Cu-DOTA-anti-CD11b
    Qizhen Cao, Qian Huang and Chun Li
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 331;
  • You have access
    Molecular imaging after external irradiation: A multiparametric approach for the assessment of radiation effects
    Markus Hartenbach, Andreas Delker, Sabrina Hartenbach, Sabrina Niedermoser, Björn Wängler, Guido Böning, Claus Belka, Viktor Meineke and Peter Bartenstein
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 332;
  • You have access
    In vivo SPECT/CT imaging of an anti-GITR antibody: A novel cancer immunotherapeutic
    Charles Glaus, Julia Piasecki, Jack Hoppin, Kelly Orcutt, Matthew Silva and Courtney Beers
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 327;
  • You have access
    Evaluation of targeted antisense radiotherapy of non-Hodgkin’s lymphoma following a fractionated dose regimen
    Dijie Liu, Varyanna Ruthengael and Michael Lewis
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 328;
  • You have access
    Imaging of KRAS2-activated early onset lung cancer in transgenic mice
    Sushil Tripathi, Kaijun Zhang, Bishnuhari Paudyal, Neil Mehta, Yong Wang, Matthew Wampole, Eric Wickstrom and Bo Lu
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 329;
  • You have access
    Development and evaluation of hypoxia-enhanced 177Lu-labeled bombesin conjugates for prostate cancer
    Nilesh Wagh, Zhengyuan Zhou, Wen Shi, Yinnong Jia, Susan Brusnahan and Jered Garrison
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 330;
  • You have access
    A novel peptide-based positron emission tomography (PET) probe for the in vivo detection of caspase activity
    Matthew Hight, Yiu-Yin Cheung, Michael Nickels, Eric Dawson, Jason Buck, Md. Imam Uddin, Ping Zhao and H. Charles Manning
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 333;
SNMMI

© 2025 SNMMI

Powered by HighWire